Q3 2022 Dare Bioscience Inc Earnings Call Transcript
Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the quarter ended September 30, 2022, and to provide a general business update. This call is being recorded. My name is Paula, and I will be your operator today. With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Daré's Chief Strategy Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer. Ms. Johnson, please proceed.
© -
Thank you. Good afternoon, and welcome to our third quarter of 2022 financial results and business update call for Daré Bioscience. Our plan today is to review our third quarter results, discuss developments since our last call in August and use the time to review our business strategy, including why we believe investment in women's health is efficient and disproportionately impactful and to highlight some important objectives and milestones anticipated through the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |